Short-Term Training, a Useful Approach for Sustainable Pharmacovigilance Knowledge Development in Tanzania, Kenya, Ethiopia and Rwanda.

Autor: van Puijenbroek E; University of Groningen, Groningen Research Institute of Pharmacy, Pharmacotherapy, Epidemiology and Economics, Groningen, The Netherlands. e.p.van.puijenbroek@rug.nl.; Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands. e.p.van.puijenbroek@rug.nl., Barry A; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden., Khaemba C; Pharmacy and Poisons Board, Nairobi, Kenya., Ntirenganya L; Rwanda Food and Drugs Authority, Kigali, Rwanda., Gebreyesus TD; Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia., Fimbo A; Tanzania Medicines and Medical Devices Authority, Dar es Salaam, Tanzania., Minzi O; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Makonnen E; Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Oluka M; Department of Pharmacology, Clinical Pharmacy and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya., Guantai A; Department of Pharmacology, Clinical Pharmacy and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya., Aklillu E; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.

Publikováno v: Drug safety [Drug Saf] 2024 Dec; Vol. 47 (12), pp. 1193-1202. Date of Electronic Publication: 2024 Aug 20.

Trends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022.

Autor: Michael F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Mirambo MM; Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania., Misinzo G; OR Tambo Africa Research Chair for Viral Epidemics, SACIDS Foundation for One Health, Sokoine University of Agriculture, Morogoro, Tanzania., Minzi O; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Beyanga M; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania., Mujuni D; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Kalabamu FS; Department of Pediatrics and Child Health, Hubert Kairuki Memorial University, Dar es Salaam, Tanzania., Nyanda EN; Mbeya Medical Research Centre, National Institute for Medical Research, Mbeya, Tanzania., Mwanyika-Sando M; Africa Academy for Public Health, Mikocheni, Dar es Salaam, Tanzania., Ndiyo D; Directorate of Regulatory Services, Government Chemist Laboratory Authority, Dodoma, Tanzania., Kasonogo R; Tanzania Medicines and Medical Devices Authority, Ministry of Health, Dodoma, Tanzania., Ismail A; Department of Mathematics and Statistics, University of Dodoma, Dodoma, Tanzania., Bahati A; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Hassan F; Health System, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Tanzania., Kaale E; Pharm R&D Lab and Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Chai JJ; District Court of Kwimba, Judiciary of Tanzania, Ngudu, Tanzania., Kinyunyi P; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Kyesi F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Tinuga F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Mongi D; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Salehe A; Immunization and Vaccine Development Program, Ministry of Health, Mnazimmoja, Zanzibar., Muhindi B; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Mdachi J; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Magodi R; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Mwenesi M; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Nyaki H; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania., Katembo B; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania., Tenga K; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania., Kasya M; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania., Mwengee W; World Health Organization, Dar es Salaam, Tanzania., Mshana SE; Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania. Electronic address: stephen72mshana@gmail.com.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Feb; Vol. 139, pp. 176-182. Date of Electronic Publication: 2023 Dec 18.

Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial.

Autor: Mlugu EM; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Minzi O; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Kamuhabwa AAR; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Dec; Vol. 110 (6), pp. 1478-1489. Date of Electronic Publication: 2021 Jun 17.

The high resistance of bacteria to clindamycin and cefepime: a call to revisit antibiotics reserved for use at tertiary hospitals in Tanzania

Autor: Bwire Gm, Kibanga W, Mwambete Kd, Marealle Ai, Mlyuka H, Kilonzi M, Minzi O, Mutagonda R, Mikomangwa Wp

Background Antibiotic resistance poses burden to the community and health care services. Efforts are being made at local, national and global level to combat the rise of antibiotic resistance including antibiotic stewardship. Surveillance to antibiot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f86e4ec781b2a12ca311f92c0f97b3bb
https://doi.org/10.21203/rs.2.22232/v1

Dyslipidemia and associated cardiovascular risk factors in HIV-positive and HIV-negative patients visiting ambulatory clinics: A hospital-based study.

Autor: Woldu MA; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences (www.muhas.ac.tz), Dar Es Salaam, Tanzania.; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University (www.aad.edu.et), Addis Ababa, Ethiopia., Minzi O; Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences (www.muhas.ac.tz), Dar Es Salaam, Tanzania., Engidawork E; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University (www.aad.edu.et), Addis Ababa, Ethiopia.

Publikováno v: JRSM cardiovascular disease [JRSM Cardiovasc Dis] 2022 Jul 21; Vol. 11, pp. 20480040221114651. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).